How Military Members Should Deal With Fitness and Health as They Age

Your military service may be the fittest time of your life, but it’s no secret that after years in a physically demanding job, the aches and pains of athletic life before the military and injuries during the military can start to add up. For some, those aches and pains may hit in the late 20s and early 30s. Others might not experience the typical pains of a life well lived until their 40s and 50s.

No matter when the wear and tear of military service catches up with you, there are countless ways to turn this process around. The common denominator is: don’t stop moving.

Several veterans ranging in VA disability ratings from 50 to 100% I spoke with recently said staying active and working hard to not gain weight are both key to reducing the effect of old injuries. How we got to this point follows a somewhat standard path – and now what it looks like might help you mitigate it for yourself.

Teen Years. Many worked hard to gain weight, put on muscle for sports, and could not eat enough food to gain weight. Many athletes or fitness buffs in their teens learn how to eat to gain weight, while others work to drop it quickly for sports like wrestling. Depending on where you were on that spectrum, you likely took those good and bad eating habits into your 20 to 30s.

Late Teens and Early 20s. As we finished growing, many learned that they were no longer a “hard gainer” and could put on both muscle and fat with relative ease. Many put on weight without even trying. And while some were able to outwork their diets, for many that subtle gain of five pounds a year turned into 50 lbs. overweight by the end of the decade. Meanwhile, depending on military job, aches and pains from running, rucking, equipment carry and other high repetition exercises started to show themselves.

Twenties into 30s. Now we’re at the decade where many started to experience job related injuries and surgeries layered on the stresses of the job, life, family and deployments. Add in combat deployments and traumatic injuries and you have an entirely new level of recovery to deal with when you come back home. That is also when the previous injuries from early life athletics, job related tasks and injuries or stress, combined with eating habits of previous decades, add to the loss of the ability to recover quickly from training, injuries and illnesses. Outworking a bad diet suddenly was near impossible.

Thirties into 40s — Many have either made the decision to leave the military by now or decided to put in 20-plus years. Regardless of your decision to continue serving or not, you cannot escape the age and athletic history. Learning new skills and following new rules at this point is absolutely required to live normally. Some of these new rules are:

  • You cannot outwork your diet. You need to eat better and usually
Read more

This Black Friday Fitbit Charge 4 deal at Amazon takes fitness tracker to its lowest ever price

Fitbit Charge 4 Special Edition is the best fitness tracker this market-leading brand makes. It’s always good value at under £150, but this deal takes it down to just £130 for one day only. It’s unlikely it will get much cheaper than that, even when the best Black Friday deals are unveiled at the end of November.

• Buy Fitbit Charge 4 Special Edition at Amazon, on sale for £129.99 – was £149.99, so you save £20 at Amazon

The Charge 4 Special Edition is functionally identical to the excellent Charge 4 but has a more premium finish. If you want a standard Charge 4, that is also discounted today and can be bought for £119.99 (£10 off RRP).

Fitbit Charge 4 Special Edition £129.99 | Was £149.99 | Save £20 at Amazon
The Fitbit Charge 4 Special Edition has all the features of the standard edition, but is made from more premium materials and boasts a nicer strap. It tracks heart rate 24/7, estimates your calories burned and monitors sleep. Unlike most older, lesser Fitbits it has GPS built in to track runs, hikes and bike rides, plus a blood oxygen sensor to track… blood oxygen. Deal ends today.View Deal

Today’s best Fitbit Charge 4 deals

Fitbit Charge 4 Fitness and…

Fitbit Charge 4 Fitness and…

Fitbit Charge 4 Fitness…

Fitbit Charge 4 Granite…

Why should you buy the Fitbit Charge 4 

Unlike its predecessor, the Fitbit Charge 4 comes with built-in GPS so you can track your activities more precisely without needing to have your phone on you all the time. Should you want to have your phone on you, you can also use the Fitbit Charge 4 to control Spotify from your wrist.

The improved Active Zone Minutes system tracks your activity levels even when you are not using a sport mode on the fitness tracker. This can give you a better understanding of just how ‘active’ you were during the day/week and prioritises exercise that really elevates your heart rate. Less strenuous activities are also tracked of course if you’re more focussed on doing your 10,000 steps per day.

The Fitbit Charge 4 has a battery life of ‘up to’ 7 days – dependent on GPS usage – and you can pay in shops with it thanks to the Fitbit Pay feature. This water resistant fitness tracker monitors your heart rate 24/7, counts calorie burned, and has 15+ pre-loaded exercise profiles. You can track your goals all day, then have it monitor and rate your sleep at night.

It also utilises the excellent Fitbit App, where you can further scrutinise your fitness and weight loss progress using easy-to-understand charts and graphs. Smartwatch-style notifications are also included.

Yet more Fitbit deals

Read more

U.S. signs deal with Lilly for supply of potential COVID-19 antibody drug

FILE PHOTO: Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake

(Reuters) – The U.S. Government has awarded an initial $375 million contract to drugmaker Eli Lilly and Co LLY.N to secure 300,000 doses of its potential experimental COVID-19 antibody treatment, a drug that has been touted by U.S. President Donald Trump.

Lilly will start delivering the treatment within two months of receiving an emergency use authorization from the U.S. health regulator, the company said.

The U.S. government also has the option to purchase up to an additional 650,000 vials for $812.5 million, the U.S. Department of Health and Human Services said in a statement.

While vaccines are seen critical to ending the pandemic, governments are increasingly looking at effective treatment options to slow the spread of the disease and kick-start economic activity.

The company submitted a request to the U.S. Food and Drug Administration earlier this month for emergency use authorization of the drug to treat mild to moderate COVID-19 patients.

The U.S. government has committed that patients will have no out-of-pocket costs for the medicine, although healthcare facilities may charge a fee for the product’s administration, Lilly said.

The antibody therapy is similar to a drug from Regeneron Pharmaceuticals REGN.O that was given to Trump during his bout with COVID-19.

The treatments belong to a class of drugs called monoclonal antibodies that are manufactured copies of antibodies created by the body to fight against an infection. Lilly’s antibody was identified from a blood sample taken from one of the first U.S. patients who recovered from COVID-19.

Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty

Source Article

Read more

VitalHub Continues to Increase NHS UK Presence with Additional Regional Licensing Deal of Synopsis Products

TORONTO, Oct. 28, 2020 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the licensing of newly-acquired subsidiary Intouch With Health’s (“Intouch”) digital, at-home pre-op solutions, Synopsis iQ, to Northumbria Healthcare NHS Foundation Trust (“Northumbria” or the “Trust”).

Northumbria Healthcare NHS Foundation Trust has licensed VitalHub subsidiary Intouch’s digital pre-operative solution platform, Synopsis iQ, as the Trust launches a new digital pre-operative assessment (POA) pathway that will improve demand and capacity planning and resource utilization, helping to fill last-minute surgery slots and reducing the number of face-to-face appointments the department processes.

The Synopsis solution will enable Northumbria to meet a number of Trust targets, such as reducing the face-to-face appointments, which has become a much-needed requirement in the pandemic climate. Synopsis will provide the Trust with tools to afford patients with an improved experience leading up to surgery, affecting both the delivery and quality of care provided.

The project is part of the Trust’s drive to create a more efficient operating room booking pathway by creating a pool of ‘pre-op ready’ patients’ consultants can use to create operating room lists and fill last-minute surgery slots. As part of the project, patients waiting for surgery will also be able to complete their POA health questionnaire at home via a secure link on the Trust’s website. Results are then sent to the Trust’s pre-operative assessment department where staff can triage and swim-lane patients into the correct fitness and readiness categories.

The Trust identified a considerable burden on pre-op assessment departments, facing high volumes of last-minute requests for patient appointments, resulting in operating time delays and resource inefficiencies. Prior to the COVID-19 pandemic, the Trust established a target to reduce the number of face-to-face appointments patients had to attend, creating a need for a pre-op pathway solution, and has selected Synopsis iQ and Synopsis Home as their solutions of choice to enable the progression of this target.

Digitizing the pre-operative assessment process will also allow consultants and anaesthetists to access full patient notes from any of the Trust’s four hospital sites. The project will be rolled out across North Tyneside General Hospital, Northumbria Specialist Emergency Care Hospital, Hexham General Hospital and Wansbeck General Hospital, giving staff across all four hospitals secure access to patient records and a real-time view of each patient’s status through the pre-operative pathway.

Northumbria Healthcare NHS Foundation Trust is a regional healthcare network that provides a range of health and care services to support more than 500,000 people living in Northumberland and North Tyneside. The Trust delivers care from 11 sites, including their emergency care hospital, general and community hospitals, outpatient and diagnostic centers, an elderly care unit and an integrated health and social care facility. The Trust admitted over 116,000 patients and handled over 368,000 outpatient appointments in the 2017/18 period.

“We are seeing an aggressive uptick in awareness and interest in the Synopsis suite of products,” said Dan Matlow, CEO of VitalHub Corp. “With this contract, we add another

Read more

Covid survivors deal with another lingering side effect: Dramatic hair loss

When Stacey Maravola’s hair started falling out in clumps two months after she tested positive for Covid-19, she was not initially concerned.

“I washed my hair one day and I’m pulling handfuls upon handfuls. And I’m like, ‘Maybe because it was up in a scrunchie,’” Maravola, 44, of Leetsdale, Pennsylvania, said.

But nearly two months later, the hair loss has not stopped. Each time Maravola, a health and lifestyle coach, shampoos her hair, fistfuls come out, getting tangled around her fingers and sticking to her legs as she showers.

“I’ve had to limit hair washes because I’m terrified,” she said. “I’m not a big emotional person, but I can tell you, this has changed me. I cry every single time I take a shower.”

Image: Stacey Maravola (Courtesy Stacey Maravola)
Image: Stacey Maravola (Courtesy Stacey Maravola)

Maravola is one of many coronavirus survivors dealing with dramatic hair loss, something that experts say is not entirely unexpected following a serious illness — but can be jarring nonetheless.

“It is upsetting, especially for those who have gone through a significant clinical course of Covid, to then experience this as well,” said Dr. Sara Hogan, a dermatologist and health sciences clinical instructor at the David Geffen School of Medicine at the University of California, Los Angeles. “But oftentimes, patients, once they have a diagnosis and they understand that typically this will get better, they feel better.”

Sudden hair loss can happen after any stressful event, including major surgery or even an emotional stressor such as starting a new job, Hogan said. The pandemic appears to have led to a large uptick in people who are seeing their hair thinning, she said: Hogan used to see an average of three to five hair loss patients a week and now sees up to seven a day.

Related:

Why severe assaults to the body or mind sometimes trigger hair loss is not entirely understood. In the majority of these cases, the patient is diagnosed with telogen effluvium, a temporary condition in which he or she sheds many more hairs than the typical 100 or so that people lose in a day. Telogen effluvium usually begins about three to six months after the stressor has happened, and in most patients, the problem will resolve within four to six months, according to Hogan. (In rare cases, unremitting stress can lead to chronic shedding, she added.)

Researchers do not believe Covid-19 attacks the hair follicles, meaning the hair loss is the body’s reaction to the physiological and emotional stress that the disease caused, rather than a symptom of the disease itself. And many hair loss patients that Hogan and other dermatologists are currently seeing have never had the coronavirus to begin with.

“It’s just all the other tolls of the pandemic that are leading to the hair loss,” such as financial worries or grieving the death of a family member, said Dr. Lauren Kole, an assistant professor of dermatology at the University of Alabama at Birmingham School of Medicine.

Hair loss following Covid-19

Read more

Trump Administration Announced Vaccine Distribution Deal With CVS, Walgreens For Care Facilities

KEY POINTS

  • The Trump administration on Friday announced a deal with CVS and Walgreens to administer COVID-19 vaccines to long-term care facilities
  • The vaccine will be free for all residents and staff members in long-term care facilities
  • Johnson & Johnson’s late-stage coronavirus vaccine was paused after a participant reported an adverse effect

The Trump administration on Friday announced a deal with CVS and Walgreens to administer COVID-19  vaccines to long-term care facilities when a safe vaccine is produced.

The vaccine will be free for all residents and staff members in long-term care facilities, including skilled nursing facilities, nursing homes, assisted living facilities, and residential care homes, the Department of Health and Human Services said in a press release.

CVS and Walgreens will coordinate on-site inoculation dates with each facility. The companies anticipate that three total visits over two months are likely to be needed to administer both doses of vaccine to residents and staff, the agency said.

“Protecting the vulnerable has been the number one priority of the Trump Administration’s response to COVID-19, and that commitment will continue through distributing a safe and effective vaccine earliest to those who need it most,” HHS Secretary Alex Azar said in a statement.

Centers for Medicare and Medicaid Services Administrator Seema Verma said the deal will ensure that nursing home residents, which have been hit hard by the virus, “are at the front of the line for the COVID vaccine and will bring their grueling trial to a close as swiftly as possible.”

The announcement comes the same day states must submit their draft plans to the federal government on how they will distribute a coronavirus vaccine if and when one is approved for public use.

Most of the potential vaccines require two doses, although Johnson & Johnson’s requires just one shot, and some of them need to be transported and stored at varying and specific temperatures.

Most notably, Johnson & Johnson’s late-stage coronavirus vaccine was paused after a participant reported an adverse effect, the company’s chief financial officer said Tuesday.

The pause will allow the data and safety monitoring board to thoroughly investigate the unexplained illness, CFO Joseph Wolk said in an interview on CNBC.

“We’re letting safety protocol follow the proper procedure here,” he said, adding that pauses in trials are “not uncommon.”

“What it should also do is reassure the public that every scientific, medical and ethical standard is being applied here,” Wolk added.

Source Article

Read more
  • Partner links